Floatz logo

Eloxatin

Pancreatic Intraductal Papillary-Mucinous Neoplasm

National Cancer Institute (NCI)Phase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Pancreatic Intraductal Papillary-Mucinous Neoplasm cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
National Cancer Institute (NCI)
Phase 3BB
Capecitabine
National Cancer Institute (NCI)
Phase 3BB
Ferumoxytol
OHSU Knight Cancer Institute
N/AD

Same molecule, other indications

Eloxatin is also rated in:

exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
colon adenocarcinomaDormant
BBB
Indicative ·
77 / 100
View asset →
colorectal neoplasmDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →